{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:27:01Z","timestamp":1784903221125,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T00:00:00Z","timestamp":1451952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ijid.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,9]],"date-time":"2016-01-09T03:01:56Z","timestamp":1452308516000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010\u20132011 influenza season in Russia"],"prefix":"10.1016","volume":"43","author":[{"given":"I.A.","family":"Leneva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.I.","family":"Burtseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.B.","family":"Yatsyshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.T.","family":"Fedyakina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.S.","family":"Kirillova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.P.","family":"Selkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Osipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.V.","family":"Maleev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2016.01.001_bib0195","first-page":"421","article-title":"Swine-origin influenza A (H1N1) virus\u2014United States and other countries","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2016.01.001_bib0200","unstructured":"Russian Statistical Yearbook. The incidence of selected infectious diseases. Statistics digest\/Rosstat. - M., 2011. \u2013 795 pp. Available at: http:\/\/www.gks.ru\/bgd\/regl\/b11_13\/IssWWW.exe\/Stg\/d2\/08-18.htm."},{"key":"10.1016\/j.ijid.2016.01.001_bib0205","series-title":"Textbook of influenza","first-page":"20","article-title":"Influenza pandemics: history and lessons learned","author":"Monto","year":"2013"},{"key":"10.1016\/j.ijid.2016.01.001_bib0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/nyas.12462","article-title":"Continuing challenges in influenza","volume":"1323","author":"Webster","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"Spec no.","key":"10.1016\/j.ijid.2016.01.001_bib0215","first-page":"110","article-title":"Influenza vaccination: a 21st century dilemma","author":"Griffin","year":"2013","journal-title":"S D Med"},{"key":"10.1016\/j.ijid.2016.01.001_bib0220","unstructured":"World Health Organization. Guidelines on the use of vaccines and antivirals during influenza pandemics: Annex 5\u2014Considerations for the use of antivirals during an influenza pandemic. Geneva: WHO; 2004. Available at: http:\/\/whqlibdoc.who.int\/hq\/2004\/WHO_CDS_CSR_RMD_2004.8_eng.pdf.(accessed September 25, 2013)."},{"key":"10.1016\/j.ijid.2016.01.001_bib0225","unstructured":"Centers for Disease Control and Prevention. Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011;60. Available at: http:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/summary-clinicians.htm (accessed March 5, 2014)."},{"key":"10.1016\/j.ijid.2016.01.001_bib0230","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1358\/dof.1992.017.12.193894","article-title":"Arbidol","volume":"17","author":"Glushkov","year":"1992","journal-title":"Drugs Future"},{"key":"10.1016\/j.ijid.2016.01.001_bib0235","unstructured":"Guskova T, Glushkov R. Efficacy and safety of arbidol in treating and prophylaxis of influenza: clinical trials. In: Glushkov R, editor. Arbidol\u2014a new antiviral, immunomodulator, interferon inducer (Russian). Moscow: Timotek; 1999, p. 63\u201376."},{"key":"10.1016\/j.ijid.2016.01.001_bib0240","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986708784049658","article-title":"Arbidol: a broad-spectrum antiviral compound that blocks viral fusion","volume":"15","author":"Boriskin","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijid.2016.01.001_bib0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.antiviral.2011.03.182","article-title":"In vitro antiviral activity of arbidol against chikungunya virus and characteristics of a selected resistant mutant","volume":"90","author":"Delogu","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2016.01.001_bib0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: an update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2016.01.001_bib0255","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2008.10.009","article-title":"Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol","volume":"81","author":"Leneva","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2016.01.001_bib0260","first-page":"84","article-title":"Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A (Russian)","volume":"77","author":"Leneva","year":"2005","journal-title":"Ter Arkh"},{"key":"10.1016\/j.ijid.2016.01.001_bib0265","first-page":"19","article-title":"Study of antiviral activity of Russian domestic anti-influenza agents in cell culture and in animal model","volume":"3","author":"Leneva","year":"2010","journal-title":"Vopr Virus (Russian)"},{"key":"10.1016\/j.ijid.2016.01.001_bib0270","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/jmv.22234","article-title":"Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions","volume":"84","author":"Brooks","year":"2012","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2016.01.001_bib0275","first-page":"20","article-title":"The specific features of the cocirculation of influenza viruses in the 2010-2011 postpandemic period according to the results of activities of the D. I. Ivanovsky Research Institute of Virology, Ministry of Health and Social Development of Russia (Russian)","volume":"57","author":"Burtseva","year":"2012","journal-title":"Vopr Virus"},{"key":"10.1016\/j.ijid.2016.01.001_bib0280","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3844\/ajidsp.2013.77.93","article-title":"Influenza surveillance in Russia based on epidemiological and laboratory data for the period from 2005 to 2012","volume":"9","author":"Sominina","year":"2013","journal-title":"Am J Infect Dis"},{"key":"10.1016\/j.ijid.2016.01.001_bib0285","unstructured":"World Health Organization. Fluorometric neuraminidase inhibitor assay: standard operating procedure WHO\u2014025. Australia: WHO Collaborating Centre for Reference and Research on Influenza; 2009. Available at: http:\/\/www.nisn.org\/documents\/A. Hurt_Protocol_for_NA_fluorescence.pdf. (accessed September 25, 2013)."},{"key":"10.1016\/j.ijid.2016.01.001_bib0290","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0042-6822(92)91187-Y","article-title":"Maturation of influenza A virus hemagglutinin\u2014estimates of the pH encountered during transport and its regulation by the M2 protein","volume":"190","author":"Grambas","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.ijid.2016.01.001_bib0295","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/JVI.62.5.1508-1512.1988","article-title":"Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection","volume":"62","author":"Belshe","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.01.001_bib0300","first-page":"10","article-title":"Pandemic influenza A\/H1N1(sw2009) in Russia: epidemiology, diagnosis, clinical picture and treatment (Russian)","volume":"82","author":"Iatsyshina","year":"2010","journal-title":"Ter Arkh"},{"key":"10.1016\/j.ijid.2016.01.001_bib0305","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nature08260","article-title":"In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses","volume":"460","author":"Itoh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2016.01.001_bib0310","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.1177238","article-title":"Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice","volume":"325","author":"Maines","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ijid.2016.01.001_bib0315","first-page":"433","article-title":"Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2016.01.001_bib0320","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2016.01.001_bib0325","unstructured":"World Health Organization. Influenza A(H1N1) virus resistance to oseltamivir\u20142008-2009 influenza season. 18 March 2009; Geneva: WHO. Available at: http:\/\/www.who.int\/influenza\/resources\/documents\/H1N1webupdate20090318_ed_ns.pdf (accessed November 3, 2009)."},{"key":"10.1016\/j.ijid.2016.01.001_bib0330","unstructured":"Summary of influenza antiviral susceptibility surveillance findings, September 2010\u2013March 2011. 6 June 2011; Geneva: WHO. Available at: http:\/\/www.who.int\/influenza\/gisrs_laboratory\/updates\/antiviral_susceptibility\/en\/ (accessed July 6, 2011)."},{"key":"10.1016\/j.ijid.2016.01.001_bib0335","first-page":"41","article-title":"Investigation of susceptibility of influenza viruses A (H1N1), the cause of infection in humans in April\u2013May 2009, to antivirals in MDCK cell culture","volume":"54","author":"Romanovskaia","year":"2009","journal-title":"Antibiot Khimioter"},{"key":"10.1016\/j.ijid.2016.01.001_bib0340","first-page":"3","article-title":"Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture","volume":"56","author":"Fediakina","year":"2011","journal-title":"Antibiot Khimioter"},{"key":"10.1016\/j.ijid.2016.01.001_bib0345","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2011.05.008","article-title":"Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets","volume":"91","author":"Govorkova","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2016.01.001_bib0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkg007","article-title":"Early administration of oral oseltamivir increases the benefits of influenza treatment","volume":"51","author":"Aoki","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2016.01.001_bib0355","unstructured":"ClinicalTrials.gov. NCT01651663. A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold (ARBITR). Principal Investigator: Oleg Kiselev, Dr. Biol. Sci. Research Institute of Influenza. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01651663?term=arbidol&rank=1 (accessed January 23, 2015)."},{"key":"10.1016\/j.ijid.2016.01.001_bib0360","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/fampra\/cms059","article-title":"Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials","volume":"30","author":"Ebell","year":"2013","journal-title":"Fam Pract"},{"key":"10.1016\/j.ijid.2016.01.001_bib0365","doi-asserted-by":"crossref","first-page":"g2545","DOI":"10.1136\/bmj.g2545","article-title":"Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments","volume":"348","author":"Jefferson","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2016.01.001_bib0370","doi-asserted-by":"crossref","first-page":"e60348","DOI":"10.1371\/journal.pone.0060348","article-title":"The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews","volume":"8","author":"Michiels","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2016.01.001_bib0375","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/508439a","article-title":"Tamiflu report comes under fire","volume":"508","author":"Butler","year":"2014","journal-title":"Nature"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2016.01.001_bib0380","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/irv.12085","article-title":"Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies","volume":"7","author":"Santesso","year":"2013","journal-title":"Influenza Other Respir Viruses"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T19:33:53Z","timestamp":1600025633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971216000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":38,"alternative-id":["S1201971216000023"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2016.01.001","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010\u20132011 influenza season in Russia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}